45
Views
8
CrossRef citations to date
0
Altmetric
Original Article

Increased Cytotoxicity Against B-Chronic Lymphocytic Leukemia by Cellular Manipulations: Potentials for Therapeutic Use

, , &
Pages 573-582 | Accepted 22 May 2000, Published online: 05 Aug 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Karen WL Yee & Susan M O’Brien. (2006) Emerging drugs for chronic lymphocytic leukaemia. Expert Opinion on Emerging Drugs 11:1, pages 167-189.
Read now
Peng Wang, Z. Steven Pavletic & Shantaram S. Joshi. (2002) Increased Apoptosis in B-chronic Lymphocytic Leukemia Cells as a Result of Cyclin D3 Down Regulation. Leukemia & Lymphoma 43:9, pages 1827-1835.
Read now

Articles from other publishers (6)

Christine E. Cutucache. (2013) Tumor-induced host immunosuppression: Special focus on CLL. International Immunopharmacology 17:1, pages 35-41.
Crossref
Guy Makin & Caroline Dive. 2011. New Agents for the Treatment of Acute Lymphoblastic Leukemia. New Agents for the Treatment of Acute Lymphoblastic Leukemia 117 141 .
Daniel E. Johnson. 2008. Sensitization of Cancer Cells for Chemo/Immuno/Radio-therapy. Sensitization of Cancer Cells for Chemo/Immuno/Radio-therapy 243 261 .
I Hus, J Roliński, J Tabarkiewicz, K Wojas, A Bojarska-Junak, J Greiner, K Giannopoulos, A Dmoszyńska & M Schmitt. (2005) Allogeneic dendritic cells pulsed with tumor lysates or apoptotic bodies as immunotherapy for patients with early-stage B-cell chronic lymphocytic leukemia. Leukemia 19:9, pages 1621-1627.
Crossref
Sanjeev Shangary, Christopher L. Oliver & Daniel E. Johnson. 2005. Apoptotic Pathways as Targets for Novel Therapies in Cancer and Other Diseases. Apoptotic Pathways as Targets for Novel Therapies in Cancer and Other Diseases 107 135 .
S Shangary & D E Johnson. (2003) Recent advances in the development of anticancer agents targeting cell death inhibitors in the Bcl-2 protein family. Leukemia 17:8, pages 1470-1481.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.